Diabetes Flashcards
Stability of Humalog Mix 50/50 pens
10 days
Stability of Humulin 70/30 pens
10 days
Stability of Humulin N pen
14 days
Stability of Novolog Mix 70/30 pens
14 days
Stability of Apidra pens/vials
28 days
Stability of Humalog pens/vials
28 days
Stability of Novolog pens/vials
28 days
Stability of Admelog pens/vials
28 days
Stability of Lyumjev pens/vials
28 days
Stability of Fiasp pens/vials
28 days
Stability of Humalog Mix 75/25 vial
28 days
Stability of Novolog Mix 70/30 vial
28 days
Stability of Novolin R U-100, N, and 70/30 pens
28 days
Stability of Humulin R U-500 pens
28 days
Stability of Lantus, Basaglar, Semglee vials and pens
28 days
Stability of Humulin R U-100, N, and 70/30 vials
28 days
Stability of Humulin R U-500 vial
40 days
Stability of Novolog R U-100, N, and 70/30 vials
42 days
Stability of Levemir vial and pen
42 days
Stability of Toujeo pen
56 days
Stability of Tresiba pen
56 days
When mixing NPH and regular insulin together in the same syringe, how do you do it?
The regular/rapid-acting insulin is added first, then the NPH insulin
Clear before cloudy!
Selecting diabetes treatment: what to avoid in a cancer patient
GLP-1 agonists, Mounjaro
Selecting diabetes treatment: avoid in gastroparesis, GI disorders
GLP-1 agonists, pramlintide, Mounjaro
Selecting diabetes treatment: avoid in genital infections, UTIs
SGLT2is
Selecting diabetes treatment: avoid in heart failure
TZDs, alogliptin, saxagliptin
Selecting diabetes treatment: avoid in hypoglycemia
insulin, SUs, meglitinides, pramlintide
Selecting diabetes treatment: avoid in hypotension/dehydration
SGLT2is
Selecting diabetes treatment: avoid in hypokalemia
insulin
Selecting diabetes treatment: avoid in ketoacidosis
SGLT2is
Selecting diabetes treatment: avoid in lactic acidosis
metformin
Selecting diabetes treatment: avoid in osteopenia/osteoporosis
canagliflozin, TZDs
Selecting diabetes treatment: avoid in pancreatitis
DPP4is, GLP-1 agonists, Mounjaro
Selecting diabetes treatment: avoid in peripheral neuropathy, PAD, foot ulcers
Invokana
Selecting diabetes treatment: avoid in sulfa allergy
SUs
Selecting diabetes treatment: avoid in renal insufficiency
metformin, exenatide, glyburide; insulin may need to be started at a lower dose
Selecting diabetes treatment: avoid in weight gain/obesity
SUs, meglitinides, TZDs, insulin
Only GLP-1 that’s renally cleared
Exenatide (Byetta, Bydureon)
BBW for GLP-1s
risk of thyroid C-cell carcinoma
GLP1s that are recommended in patients with ASCVD risk
liraglutide (Victoza), dulaglutide (Trulicity), SQ semaglutide (Ozempic)
Effects of GLP1s
increase glucose-dependent insulin secretion, decrease glucagon secretion, slows gastric emptying, improves satiety, weight loss
SGLT2is are CI’ed in what?
dialysis
SGLT2is effects
reduce reabsorption of glucose, increase urinary glucose excretion
SGLT2s that are beneficial in HF, CKD, ASCVD
Jardiance, Farxiga, Invokana
eGFR minimum for SGLT2i use
≥20ml
Metformin MoA
decrease hepatic glucose production, increase insulin sensitivity, decreased intestinal absorption of glucose
BBW for metformin
lactic acidosis
MoA of SUs and meglitinides
Stimulate insulin secretion from the pancreatic beta-cells to decrease postprandial BG
DPP4is MoA
prevent DPP4 from breaking down incretin hormones, GLP-1, and GIP
DPP4i effects
increase insulin release from pancreatic beta cells and decreased glucagon secretion
DPP4i warnings
pancreatitis, severe arthralgia, acute renal failure, risk of heart failure
TZD MoA
increase peripheral insulin sensitivity
BBW for TZDs
can cause or exacerbate HF
Warnings for TZDs
edema, risk of fractures, can stimulate ovulation
Acarbose, miglitol MoA
inhibit the metabolism of intestinal sucrose, which delays glucose absorption
Colesevelam side effect
Constipation
Bromocriptine CI
syncopal migraines, breastfeeding
Pramlintide side effect
Significant hypoglycemia risk; reduce mealtime insulin dose by 50% when starting
Drugs that can increase BG
Beta-blockers
Thiazide and loops
Transplant drugs (tacrolimus, cyclosporine)
Protease inhibitors
Quinolones
APS (olanzapine and quetiapine)
Statins
systemic steroids
cough syrups
niacin
Drugs that can decrease BG
beta-blockers, tramadol, quinolones
DKA and HHS treatment: first step
FLUIDS! Start with NS, then change to D5W1/2NS when BG <200
DKA and HHS treatment: second step
Regular insulin infusion
DKA and HHS: what else to monitor
Potassium level
When to treat acidosis in DKA/HHS
If pH <6.9, give sodium bicarb